‘Are we just going to give up and die like every other generation?’
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Robby Wade demonstrated Rythm Health’s at‑home blood‑draw kit, using Tasso devices and heating pads, for a crowd of about 100 at the Vitalist Bay conference in Berkeley.
- Adam Gries opened the Vitalist Bay event with the question “Are we just going to give up and die like every other generation?” framing the gathering’s anti‑aging mission.
- Christine Peterson said the longevity field is transitioning from a movement to an industry but still battles public skepticism and the perception that “billionaires who want to live forever” are the main drivers, noting that billionaire funding remains insufficient.
- Lon reported that global investment in longevity companies more than doubled in 2024, reaching $8.5 billion, underscoring rapid capital inflows despite the field’s small size.
- BioAge Labs co‑founder led a workshop on longevity therapeutics at the conference, highlighting emerging treatments alongside unconventional activities like Krav Maga and sound baths.
Why it matters: Public skepticism remains a hurdle for the industry, even as $8.5 billion in funding fuels rapid product development, accelerates clinical trials, and intensifies regulatory scrutiny for investors.
